Recently, evidence was provided, using gene-deficient mice, for the involvement of the GM-CSF/CCL17 pathway in the development of pain-like behaviour and maximal disease in three experimental OA models, as well as for the exacerbated OA development due to obesity [11]. The gene discussed is CCL17; the disease is obesity due to melanocortin 4 receptor deficiency.